Nov 29, 2018
Prometic bags USD 50 Million stock sale option to ease a cash crunch Prometic Life Sciences got into an agreement for selling USD 50 million in stock. This gives Prometic a way to escape its current financial pressures. Canada-based Prometic was asked by the FDA to make and validate process changes for Ryplazim, a c...
Read More...
Apr 05, 2017
Lightweight sneakers, energy bars, high protein cereals, electrolyte cocktails- all of these promise the performance of a star athlete but rarely do the customers get even close to the peak level performance of those athletes. Even though billions are spent in sales, there is no satisfying example of performance thr...
Read More...
Discover How Learning Disability Treatment Landscape is Evolving with the Emergence of Digital Assistant Technologies
Jul 04, 2025
A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray
Jun 10, 2025
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
Newsletter/Whitepaper